Connect with BUHLMANN at DDW 2018

BUHLMANN-ddw2018-Walter E Washngton Convention Center

Digestive Diseases Week (DDW) 2018

BUHLMANN Diagnostics Corp 

Booth: #2347

June 02-05, 2018 | Walter E. Washington Convention Center | Washington, DC

Come by our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio:

Quantum Blue® platform offering rapid and quantitative results for fecal calprotectinserum calprotectinCRP and serum infliximab trough levels  (Additional trough level assays coming soon!)

Health Canada Licenses: Quantum Blue®  fCAL: 83477, Quantum Blue® fCAL extended: 100161
US: Research Use Only. Not for use in diagnostic procedures in the US

BÜHLMANN fCAL® ELISAaccurate, precise, efficient calprotectin testing

Health Canada License: 80726
US: Research Use Only. Not for use in diagnostic procedures in the US

BÜHLMANN fCAL® turbo, the new high throughput, random access fecal calprotectin assay – unique in speed, quality, flexibility

Health Canada License: 96808
US: Research Use Only. Not for use in diagnostic procedures in the US

CALEX® Cap for rapid, clean, consistent and safe stool extraction

Health Canada License: 98839
US: Research Use Only. Not for use in diagnostic procedures in the US

Click & Contact DDW 2018 BUHLMANN Team

Connect with our team ahead of time, learn more about our Calprotectin Assays or schedule a meeting!

Collin Shaw, VP of Business Development

Jennifer Stuart, Technical Sales Specialist

COLLIN SHAW
VP of Business Development

cms@buhlmannlabs.com

JENNIFER STUART
Technical Sales Specialist

jls@buhlmannlabs.com